Clinical experience with α-galactosylceramide (KRN7000) in patients with advanced cancer and chronic hepatitis B/C infection.

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)130-141
JournalClinical Immunology
Volume140
Issue number2
DOIs
Publication statusPublished - 2011

Cite this